The effect of PDE5 inhibitors on bone and oxidative damage in ovariectomy-induced osteoporosis

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Experimental biology and medicine

• Publication date

  2017-04-11

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1177/1535370217703352PMID 28399643PMCID PMC5444643
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Novel, Direct NO Donor Regulates Osteoblast and Osteoclast Functions and Increases Bone Mass in Ovariectomized Mice

  2017cited by this paper
• [Phosphodiesterase-5 inhibitors for the treatment of pulmonary arterial hypertension].

  2015cited by this paper
• EFFECTS OF SILDENAFIL ON THE INFLAMMATORY AND REPAIR PHASE OF BONE HEALING SPEED IN A RAT MODEL

  2015cited by this paper
• Biochemical markers of bone turnover – uses and limitations

  2014cited by this paper
• Screening, diagnosis and treatment of osteoporosis: a brief review.

  2014cited by this paper
• Sildenafil promotes eNOS activation and inhibits NADPH oxidase in the transgenic sickle cell mouse penis.

  2014cited by this paper
• Bone: Oxidative stress and osteoporosis

  2014cited by this paper
• Inhibition of phosphodiesterase 5 reduces bone mass by suppression of canonical Wnt signaling

  2014influential reference
• The effect of sildenafil and udenafil on testicular damage following ischemia-reperfusion injury in rats.

  2014cited by this paper
• Tadalafil enhances working memory, and reduces hippocampal oxidative stress in both young and aged mice.

  2014cited by this paper
• Udenafil: efficacy and tolerability in the management of erectile dysfunction

  2013cited by this paper
• The phosphodiesterase-5 inhibitor vardenafil reduces oxidative stress while reversing pulmonary arterial hypertension.

  2013cited by this paper
• Osteoporosis influences osteogenic but not angiogenic response during bone defect healing in a rat model.

  2013cited by this paper
• NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis.

  2013cited by this paper
• Nitric Oxide Donors for the Treatment of Osteoporosis

  2012cited by this paper
• Coenzyme Q10 supplementation and exercise-induced oxidative stress in humans.

  2012cited by this paper
• Sildenafil accelerates fracture healing in mice

  2011cited by this paper
• Estimating bisphosphonate use and fracture reduction among US women aged 45 years and older, 2001–2008

  2011cited by this paper
• Effects of ovariectomy on bone metabolism and bone mineral density in spontaneously diabetic Torii-Lepr(fa) rats.

  2011cited by this paper
• Phosphodiesterase-5 inhibitors may facilitate bone defect recovery.

  2011cited by this paper
• [Phosphodiesterase type 5 inhibitors in the treatment of pulmonary arterial hypertension].

  2010cited by this paper
• Nitric oxide and bone

  2010influential reference
• A Phosphodiesterase-5 Inhibitor Vardenafil Enhances Angiogenesis Through a Protein Kinase G-Dependent Hypoxia-Inducible Factor-1/Vascular Endothelial Growth Factor Pathway

  2010cited by this paper
• Cyclic GMP and Protein Kinase G Control a Src-Containing Mechanosome in Osteoblasts

  2010cited by this paper
• Acute effect of phosphodiesterase type 5 inhibitor on serum oxidative status and prolidase activities in men with erectile dysfunction

  2010cited by this paper
• Rapid progress for non-nuclear estrogen receptor signaling.

  2010cited by this paper
• cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action

  2010cited by this paper
• Serum Nitric Oxide Metabolite Levels in Groups of Patients with Various Diseases in Comparison of Healthy Control Subjects

  2010cited by this paper
• Postmenopausal women with osteoporosis may be associated with high endothelin-1

  2009cited by this paper
• Short-Term Changes in Serum PINP Predict Long-Term Changes in Trabecular Bone in the Rat Ovariectomy Model

  2008cited by this paper
• The laboratory rat as an animal model for osteoporosis research.

  2008cited by this paper
• Oxidative stress, free radicals and bone remodeling

  2008cited by this paper
• Nitric oxide: novel therapy for osteoporosis.

  2008influential reference
• cGMP-dependent and -independent angiogenesis-related properties of nitric oxide.

  2007cited by this paper
• Mechanism of Phosphodiesterase 5 inhibitor relief of prostatitis symptoms.

  2007cited by this paper
• Short- to mid-term effects of ovariectomy on bone turnover, bone mass and bone strength in rats.

  2007cited by this paper
• Rationale for Using Nitric Oxide Donor Therapy for Prevention of Bone Loss and Treatment of Osteoporosis in Humans

  2007cited by this paper
• Phosphodiesterase regulation of nitric oxide signaling.

  2007cited by this paper
• cGMP-dependent and -independent angiogenesis-related properties of nitric oxide

  2007cited by this paper
• Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage.

  2005cited by this paper
• Ovariectomy‐Induced Bone Loss Varies Among Inbred Strains of Mice

  2005cited by this paper
• Asymmetric dimethylarginine is not involved in ovariectomy-induced osteopenia in rats.

  2005cited by this paper
• Sildenafil citrate therapy for pulmonary arterial hypertension.

  2005cited by this paper
• Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction

  2005cited by this paper
• Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy

  2005cited by this paper
• Sildenafil citrate and sildenafil nitrate (NCX 911) are potent inhibitors of superoxide formation and gp91phox expression in porcine pulmonary artery endothelial cells

  2005cited by this paper
• Phosphodiesterase 5 Inhibitors for Erectile Dysfunction

  2005cited by this paper
• Nitrate tolerance, oxidative stress, and mitochondrial function: another worrisome chapter on the effects of organic nitrates.

  2004cited by this paper
• Assay of coenzyme Q10 in plasma by a single dilution step.

  2004cited by this paper
• Pathophysiological Roles of Nitric Oxide: In the Heart and the Coronary Vasculature

  2004cited by this paper
• Effect of PDE5 inhibition combined with free oxygen radical scavenger therapy on erectile function in a diabetic animal model

  2003cited by this paper
• Novel effects of nitric oxide.

  2003cited by this paper
• Effect of age on bone mineral density and the serum concentration of endogenous nitric oxide synthase inhibitors in rats.

  2002cited by this paper
• Screening for Postmenopausal Osteoporosis: A Review of the Evidence for the U.S. Preventive Services Task Force

  2002cited by this paper
• Assay of coenzyme Q(10) in plasma by a single dilution step.

  2002cited by this paper
• Oxidant-antioxidant system: role and significance in human body.

  2002cited by this paper
• Thyrotropin receptors in brown adipose tissue: thyrotropin stimulates type II iodothyronine deiodinase and uncoupling protein-1 in brown adipocytes.

  2001cited by this paper
• Nitric oxide and bone

  2001cited by this paper
• Evaluation of a sensitive HPLC method for the determination of Malondialdehyde, and application of the method to different biological materials

  2000cited by this paper
• The biphasic effects of nitric oxide in primary rat osteoblasts are cGMP dependent.

  2000cited by this paper
• Free radical and antioxidant protocols. Introduction.

  1998cited by this paper
• Free radical and antioxidant protocols

  1998cited by this paper
• Simultaneous detection of ubiquinol and ubiquinone in human plasma as a marker of oxidative stress.

  1997cited by this paper
• Nitric oxide donor alleviates ovariectomy-induced bone loss.

  1996cited by this paper
• Antigen Retrieval Technique: A Novel Approach to Immunohistochemistry on Routinely Processed Tissue Sections

  1996cited by this paper
• Measurement of oxidized and methylated DNA bases by HPLC with electrochemical detection.

  1996cited by this paper
• Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group.

  1994cited by this paper
• Assays of oxidative DNA damage biomarkers 8-oxo-2'-deoxyguanosine and 8-oxoguanine in nuclear DNA and biological fluids by high-performance liquid chromatography with electrochemical detection.

  1994cited by this paper
• 8-Hydroxydeoxyguanosine as a urinary biomarker of oxidative DNA damage.

  1993cited by this paper
• Osteoclastic inhibition: an action of nitric oxide not mediated by cyclic GMP.

  1991cited by this paper

• Phosphodiesterase inhibitors as emerging therapeutics for skeletal disorders: A comprehensive review of mechanisms and repurposing potential.

  2026cites this paper
• Possible Retinotoxicity of Long-term Vardenafil Treatment.

  2024cites this paper
• Tadalafil and Steroid Hormones Interactions in Adipose, Bone and Prostate Tissues: Focus on Translational Perspectives

  2022cites this paper
• POTENTIAL BENEFIT TO BLOOD FLOW BUT UNCLEAR IF CLINICALLY MEANINGFUL

  2022cites this paper
• Inhibition of Phosphodiesterase 5 Promotes the Aromatase-Mediated Estrogen Biosynthesis in Osteoblastic Cells by Activation of cGMP/PKG/SHP2 Pathway

  2021cites this paper
• Do avanafil and zaprinast exert positive effects on bone tissue via the nitric oxide/cyclic guanosine monophosphate/protein kinase-G signaling pathway in rats with ovariectomy-induced osteoporosis?

  2021influential citation
• Therapeutic potential of phosphodiesterase inhibitors in the treatment of osteoporosis: scopes for therapeutic repurposing and discovery of new oral osteoanabolic drugs.

  2021cites this paper
• ANNALS OF THE NEW YORK ACADEMY OF SCIENCES MARROW

  2021cites this paper
• Stimulating effects of vardenafil, tadalafil, and udenafil on vascular endothelial growth factor, angiogenesis, vitamin D3, bone morphogenic proteins in ovariectomized rats

  2020cites this paper
• Skeletal restoration by phosphodiesterase 5 inhibitors in osteopenic mice: Evidence of osteoanabolic and osteoangiogenic effects of the drugs.

  2020cites this paper
• Can zaprinast and avanafil induce the levels of angiogenesis, bone morphogenic protein 2, 4 and 7 in kidney of ovariectomised rats?

  2020cites this paper
• Zaprinast and avanafil increase the vascular endothelial growth factor, vitamin D3, bone morphogenic proteins 4 and 7 levels in the kidney tissue of male rats applied the glucocorticoid

  2020cites this paper
• Repurposing erectile dysfunction drugs tadalafil and vardenafil to increase bone mass

  2020cites this paper
• Do Avanafil and Zaprinast Change Some Selected Cytokine Levels in Ovariectomized Rat's Liver?

  2020cites this paper
• Phosphodiesterase‐5 inhibition improves bone regeneration at the early stages of ischemic osteonecrosis of the femoral head in rats

  2020cites this paper
• Experimental analysis of the quality of an implant embedded in the bone based on its mechanical parameters

  2019cites this paper
• Oxidative DNA Damage and NOX4 Levels in Children with Undescended Testes

  2019cites this paper
• Vardenafil and cilostazol can improve vascular reactivity in rats with diabetes mellitus and rheumatoid arthritis co-morbidity.

  2019cites this paper
• Vaspin protects mouse mesenchymal stem cells from oxidative stress-induced apoptosis through the MAPK/p38 pathway

  2019cites this paper
• In vitro and in vivo evaluation of novel Tadalafil/β-TCP/Collagen scaffold for bone regeneration: A rabbit critical-size calvarial defect study

  2019cites this paper
• PDE -5 inhibitors’ implications in women: Are they of help?

  2019cites this paper
• Adjuvant drug-assisted bone healing: Part II – Modulation of angiogenesis

  2019cites this paper
• Ex Vivo Evaluation of Hip Fracture Risk by Proximal Femur Geometry and Bone Mineral Density in Elderly Chinese Women

  2018cites this paper
• Ginsenoside Rb1 does not halt osteoporotic bone loss in ovariectomized rats

  2018cites this paper
• Effects of the Phosphodiesterase-5 (PDE-5) Inhibitors, Avanafil and Zaprinast, on Bone Remodeling and Oxidative Damage in a Rat Model of Glucocorticoid-Induced Osteoporosis

  2018influential citation